Benzenepentanamide,N-[(2S,5S)-1,2,3,4,5,6-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-3-oxo-1,4-benzodiazocin-8-yl]-3,5-bis(trifluoromethyl)- (497259-27-5)

Identification
Name:	Benzenepentanamide,N-[(2S,5S)-1,2,3,4,5,6-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-3-oxo-1,4-benzodiazocin-8-yl]-3,5-bis(trifluoromethyl)-
CAS:	497259-27-5
Molecular Formula:	C₂₈H₃₃F₆N₃O₃
Molecular Structure:
Properties
Safety Data

Other Product

Benzenepentanamide,N-[(2S,5S)-1,2,3,4,5,6-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-3-oxo-1,4-benzodiazocin-8-yl]-4-(trifluoromethyl)-
Benzenepentanamide,N-[(2S,5S)-1,2,3,4,5,6-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-3-oxo-1,4-benzodiazocin-8-yl]-
Hexanamide,N-[(2S,5S)-1,2,3,4,5,6-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-3-oxo-1,4-benzodiazocin-8-yl]-
2,4-Pentadienamide,N-[(2S,5S)-1,2,3,4,5,6-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-3-oxo-1,4-benzodiazocin-8-yl]-5-phenyl-, (2E,4E)-
2,4-Hexadienamide,N-[(2S,5S)-1,2,3,4,5,6-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-3-oxo-1,4-benzodiazocin-8-yl]-, (2E,4E)-
2,4-Pentadienamide,N-[(2S,5S)-1,2,3,4,5,6-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-3-oxo-1,4-benzodiazocin-8-yl]-5-[4-[(1E)-3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octenyl]phenyl]-, (2E,4E)-
1,4-Benzodiazocin-3(2H)-one,1,4,5,6-tetrahydro- 5-(hydroxymethyl)-1-methyl-2-(1- methylethyl)-,(2S,5S)-
1,4-Benzodiazocin-3(2H)-one,8-(1-decynyl)-1,4,5,6-tetrahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-, (2S,5S)-
1,4-Benzodiazocin-3(2H)-one,1,4,5,6-tetrahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-8-nitro-,(2S,5S)-
1,4-Benzodiazocin-3(2H)-one,8-(1-decynyl)-1,4,5,6-tetrahydro-5-(hydroxymethyl)-7-methoxy-1-methyl-2-(1-methylethyl)-, (2S,5S)-
1,4-Benzodiazocin-3(2H)-one,5-[(acetyloxy)methyl]-1,4,5,6-tetrahydro-1-methyl-2-(1-methylethyl)-,(2S,5S)-
Benzenepentanamide,N-[5-(diethylamino)-2,3-dihydro-1-methyl-2-oxo-1H-1,4-benzodiazepin-3-yl]-
2(3H)-Furanone,dihydro-3-hydroxy-5-[(1R,4R,5S,6R,8S)-8-(hydroxymethyl)-1-methyl-7-methylene-4-(1-methylethyl)bicyclo[3.2.1]oct-6-yl]-,(3R,5S)-
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-, (2S,5S)-
Spiro[3H-indole-3,7'(6'H)-[3,6]methano[3H]oxepino[4,3-b]pyrrol]-2(1H)-one,2'-[(1R)-2-[(3S,3aS,4R,5S,6aS)-hexahydro-4-(hydroxymethyl)-5-methyl-2-oxo-2H-cyclopenta[b]furan-3-yl]-1-methylethyl]-3'a,4',8',8'a-tetrahydro-1-methoxy-,(3S,3'R,3'aS,6'R,8'aS)- (9CI)
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-[4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]butyl]-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-,[2S-(2R*,5S*)]- (9CI)
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,7-[(3,4-dihydro-2H-pyrrol-5-yl)carbonyl]-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-,(2S,5S)- (9CI)
1H-1-Benzazepin-5-amine,2,3,4,5-tetrahydro-7-methyl-N-(2-methyl-2H-tetrazol-5-yl)-1-(4-pyridinylmethyl)-8-(trifluoromethyl)-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]-,(5S)-
Carbonic acid, (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl[(1R,2S,5S)-4-oxo-3-oxabicyclo[3.2.0]hept-6-en-2-yl]methyl ester
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-[(1R)-1-ethenyl-1,5-dimethyl-4-hexen-1-yl]-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-,(2S,5S)-